Synopsis

Timetric’s, 'Life Insurance Investments in Australia to 2016: Market Databook' contains detailed historic and forecast data covering investments in the life insurance industry. This databook provides data on corporate bonds, investment funds, cash in bank/hand, others investments and total investment income.

Summary

This report is the result of Timetric’s extensive market research covering the life insurance industry in Australia. It contains detailed historic and forecast data for investments. 'Life Insurance Investments in Australia to 2016: Market Databook' provides detailed insight into the operating environment of the life insurance industry in Australia. It is an essential tool for companies active across the Australian life insurance value chain and for new players considering to enter the market.

Scope

- Historic and forecast data for investments in the Australian life insurance industry for the period 2007 through to 2016
- Historic and forecast data on corporate bonds, investment funds, cash in bank/hand, others investments and total investment income

Reasons To Buy

- This report provides you with valuable data for the life insurance industry covering investments in Australia
- This report provides you with a breakdown of market data including data on corporate bonds, investment funds, cash in bank/hand, others investments and total investment income
- This report allows you to plan future business decisions using the forecast figures given for the market

Table Of Contents


1 INTRODUCTION
1.1 What is this Report About?
1.2 Definitions
2 INDUSTRY ANALYSIS
2.1 Corporate Bonds
2.2 Corporate Bonds Forecast
2.3 Investment Funds
2.4 Investment Funds Forecast
2.5 Cash in bank/hand
2.6 Cash in bank/hand Forecast
2.7 Other Investments
2.8 Other Investments Forecast
2.9 Total Investment Income
2.1 Total Investment Income Forecast
3 APPENDIX
3.1 Methodology
3.2 Contact Us
3.3 About Timetric
3.4 Disclaimer

List of Tables

Table 1: Insurance Industry Definitions
Table 2: Corporate Bonds (US$ Billion), 2007-2011
Table 3: Corporate Bonds (AUD Billion), 2007-2011
Table 4: Corporate Bonds (US$ Billion), 2011-2016
Table 5: Corporate Bonds (AUD Billion), 2011-2016
Table 6: Investment Funds (US$ Billion), 2007-2011
Table 7: Investment Funds (AUD Billion), 2007-2011
Table 8: Investment Funds (US$ Billion), 2011-2016
Table 9: Investment Funds (AUD Billion), 2011-2016
Table 10: Cash in bank/hand (US$ Billion), 2007-2011
Table 11: Cash in bank/hand (AUD Billion), 2007-2011
Table 12: Cash in bank/hand (US$ Billion), 2011-2016
Table 13: Cash in bank/hand (AUD Billion), 2011-2016
Table 14: Other Investments (US$ Billion), 2007-2011
Table 15: Other Investments (AUD Billion), 2007-2011
Table 16: Other Investments (US$ Billion), 2011-2016
Table 17: Other Investments (AUD Billion), 2011-2016
Table 18: Total Investment Income (US$ Billion), 2007-2011
Table 19: Total Investment Income (AUD Billion), 2007-2011
Table 20: Total Investment Income (US$ Billion), 2011-2016
Table 21: Total Investment Income (AUD Billion), 2011-2016

List of Figures

Figure 1: Corporate Bonds (US$ Billion), 2007-2011
Figure 2: Corporate Bonds (US$ Billion), 2011-2016
Figure 3: Investment Funds (US$ Billion), 2007-2011
Figure 4: Investment Funds (US$ Billion), 2011-2016
Figure 5: Cash in bank/hand (US$ Billion), 2007-2011
Figure 6: Cash in bank/hand (US$ Billion), 2011-2016
Figure 7: Other Investments (US$ Billion), 2007-2011
Figure 8: Other Investments (US$ Billion), 2011-2016
Figure 9: Total Investment Income (US$ Billion), 2007-2011
Figure 10: Total Investment Income (US$ Billion), 2011-2016

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Top 50 Big Pharma Partnering and M&A Deal Trends

Top 50 Big Pharma Partnering and M&A Deal Trends

  • $ 3 295
  • Industry report
  • October 2014
  • by Currentpartnering

Summary The Top 50 Big Pharma Partnering and M&A Deal Trends report provides comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. ...

Pharma and Biotech M&A Trends 2009-2014

Pharma and Biotech M&A Trends 2009-2014

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma companies. ...

Upstream Oil and Gas Quarterly Deals Review, Q2 2014

Upstream Oil and Gas Quarterly Deals Review, Q2 2014

  • $ 1 500
  • Industry report
  • August 2014
  • by Global Data

Upstream Oil and Gas Quarterly Deals Review, Q2 2014 Summary GlobalData's “Upstream Oil and Gas Quarterly Deals Review, Q2 2014” report is an essential source of data and trend analysis on mergers ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.